InsidersTradesSigma
Browse the complete record of transactions filed by Fountain Nathan B, Director. Officer active across 1 companies, notably Acumen Pharmaceuticals, Inc.. Aggregated, 2 disclosures have been recorded. Total volume traded: €169k. The latest transaction was disclosed on 6 July 2021 (Acquisition). Regulator: SEC (Form 4). The full history is free.
2 of 2 declarations
Nathan B. Fountain is a Board Member at Acumen Pharmaceuticals, Inc. He plays a key role in the governance of the company, contributing to strategic decision-making and the overall direction of the organization. His experience is valuable for Acumen.